This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Necrotic Enteritis Treatment Market

Market Insights on Necrotic Enteritis Treatment covering sales outlook, demand forecast & up-to-date key trends

Necrotic Enteritis Treatment Market By Drug Class (Inter-Alpha-Inhibitor-Proteins, Antibiotics and Dietary Supplements), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores) & Region - Forecast 2022-2032

Necrotic Enteritis Treatment Market Overview

Global necrotic enteritis treatment demand is anticipated to be valued at US$ 25 Billion in 2022, forecast to grow at a CAGR of 7.18% to be valued at US$ 50 Billion from 2022 to 2032.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 20 Billion

Expected Market Value (2022)

US$ 25 Billion

Anticipated Forecast Value (2032)

US$ 50 Billion

Projected Growth Rate (2022-2032)

7.18% CAGR

Necrotic enteritis, also known as necrotizing enterocolitis, is an inflammatory bowel disease that affects prematurely born babies. Premature infants are those who are born before 37 weeks of pregnancy. According to the World Health Organization (WHO), approximately 15 million premature babies are born worldwide each year, with the number steadily increasing, and approximately 1 million babies die as a result of this condition.

India has the highest number of preterm births, followed by China, Nigeria, Pakistan, Indonesia, the United States, Bangladesh, the Philippines, Congo, and Brazil. Although the causes of necrotic enteritis are unknown, in December 2018, researchers at Johns Hopkins University School of Medicine discovered the molecular cause of the condition, which is likely to be related to brain injury.

Necrotic enteritis is more likely to occur in prematurely born infants who have been infected. Necrotic enteritis affects 10–12% of prematurely born infants and the majority of cases result in death.

Which are Some Prominent Drivers Spearheading Necrotic Enteritis Treatment Market Growth?

The rising prevalence of preterm births in both developed and developing countries remains a major market driving factor in the necrotic enteritis treatment market. Increased access to good healthcare, increased awareness, and medical attention to pregnancy-related complications all contribute to an increase in treatment-seeking, which drives the growth of the necrotic enteritis treatment market.

The necrotic enteritis treatment market is heavily influenced by ongoing research to identify a causative factor, and breakthrough results may significantly increase revenue generation in the near future. Increased funding for research and development in the necrotic enteritis treatment market by probiotic manufacturing companies is expected to fuel market growth.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Necrotic Enteritis Treatment Industry?

The time-consuming nature of developing new breakthrough treatments may impede the growth of the necrotic enteritis treatment market. The unknown cause of necrotic enteritis further limits treatment options, which are frequently ineffective, limiting necrotic enteritis treatment revenue generation.

Why is Asia-Pacific emerging as an Opportunistic Necrotic Enteritis Treatment Market?

Because of the high prevalence of preterm births in the region, Asia-Pacific is expected to be the second most lucrative necrotic enteritis treatment market. India and China are among the countries with the highest number of preterm births per year, which can have a significant impact on the necrotic enteritis treatment market.

Although the incidence of preterm birth is higher in the APAC region, a low rate of treatment seeking and product adoption limit the potential revenue generation of the necrotic enteritis treatment market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is North America Contributing to Growth of the Necrotic Enteritis Treatment Market?

According to Future Market Insights, Because of the higher treatment seeking rate, the global necrotic enteritis treatment market is expected to be dominated by the North American necrotic enteritis treatment market.

Market Competition

Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc. Bayer International, Alcon Laboratories, Inc., Bausch & Lomb Incorporated, GlaxoSmithKline plc. and Others are the key players in the global necrotic enteritis treatment market.

Attributed to the presence of such high number of participants, the market is highly competitive.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 7.18% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Drug Class
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Poland
  • Russia
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Prometic Life Sciences Inc.
  • BioGaia Probiotics
  • Fresenius Kabi AG
  • Actavis Plc.
  • Bayer International
  • Alcon Laboratories, Inc.
  • Bausch & Lomb Incorporated
  • GlaxoSmithKline plc.

Customization

Available Upon Request

Key Segments Profiled in the Necrotic Enteritis Treatment Industry Survey

By Drug Class:

  • Necrotic Enteritis Treatment through Inter-Alpha-Inhibitor-Proteins ("IaIp")
  • Necrotic Enteritis Treatment through Antibiotics
  • Necrotic Enteritis Treatment through Dietary Supplements

By Distribution Channel:

  • Necrotic Enteritis Treatment Sales via Hospital Pharmacies
  • Necrotic Enteritis Treatment Sales via Retail Pharmacies
  • Necrotic Enteritis Treatment Sales via Online Pharmacies
  • Necrotic Enteritis Treatment Sales via Drug Stores

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific
  • Japan
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global Necrotic Enteritis Treatment market to expand at a 7.18% value CAGR by 2032

North America is expected to be the most opportunistic necrotic enteritis treatment market

Prometic Life Sciences Inc., BioGaia Probiotics, Fresenius Kabi AG, Actavis Plc., and Bayer International, are some prominent Necrotic Enteritis Treatment manufacturers

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Necrotic Enteritis Treatment Market